The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Estrella Immunopharma, Inc. quarterly Current Ratio history and growth rate from Q2 2022 to Q4 2024.
Estrella Immunopharma, Inc. Current Ratio for the quarter ending December 31, 2024 was 269 %.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period
Value
YoY Chg
Change %
Date
Q4 2024
269
Dec 31, 2024
Q3 2024
668
Sep 30, 2024
Q2 2023
23.8
-521
-95.6%
Jun 30, 2023
Q1 2023
13.3
Mar 31, 2023
Q4 2022
38.6
Dec 31, 2022
Q3 2022
134
Sep 30, 2022
Q2 2022
545
Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.